Titre:
  • Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
Auteur:Roufosse, Florence; Kahn, Jean-Emmanuel; Rothenberg, Marc; Wardlaw, Andrew; Klion, Amy; Kirby, Suyong Yun; Gilson, Martyn M.J.; Bentley, Jane J.H.; Bradford, Eric E.S.; Yancey, Steven S.W.; Steinfeld, Jonathan; Gleich, Gerald
Informations sur la publication:Journal of allergy and clinical immunology
Statut de publication:Publié, 2020
Sujet CREF:Immunologie
Allergie et immunopathologie
Mots-clés:efficacy
flare
Hypereosinophilic syndrome
mepolizumab
safety
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0091-6749
info:doi/10.1016/j.jaci.2020.08.037
info:pii/S0091674920312768
info:scp/85092787899
info:pmid/32956756